< Back to companies

Nextbio is a privately owned software company that provides an innovative platform for life science researchers and drug development teams to search, discover, and share knowledge across public and proprietary biological and genomic data. The Nextbio Platform is an ontology-based semantic framework that integrates heterogeneous data types—including gene, tissue, disease, and compound information—from multiple organisms and platforms. It enables researchers to identify prognostic and predictive molecular signatures, accelerate drug discovery, and improve collaboration across therapeutic areas and geographic locations. The platform is delivered as a SaaS solution, supporting rapid deployment and integration of internal data with public datasets.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2018
Website
nextandbio.com/en/?ckattempt=1

Categories

Life SciencesResearch, Evidence & KnowledgeHealth Data & ITScientific Publishing & Knowledge
Only accessible to MedStartr community members. Join now

What do you think of Nextbio?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now